{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:16:38Z","timestamp":1757621798201,"version":"3.44.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82201573"],"award-info":[{"award-number":["82201573"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01836-1","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T04:35:39Z","timestamp":1754714139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analyses of NOTCH3 variants in Chinese patients with clinically diagnosed Alzheimer's disease and frontotemporal dementia"],"prefix":"10.1186","volume":"17","author":[{"given":"Haitian","family":"Nan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailing","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"issue":"3","key":"1836_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000452256","volume":"81","author":"G Nicolas","year":"2016","unstructured":"Nicolas G, Charbonnier C, Campion D. From common to rare variants: the genetic component of Alzheimer disease. Hum Hered. 2016;81(3):129\u201341.","journal-title":"Hum Hered"},{"issue":"5","key":"1836_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101082","volume":"26","author":"G Nicolas","year":"2024","unstructured":"Nicolas G, Zarea A, Lacour M, et al. Assessment of Mendelian and risk-factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening. Genet Med. 2024;26(5): 101082.","journal-title":"Genet Med"},{"issue":"1","key":"1836_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/alz.12005","volume":"16","author":"L Jia","year":"2020","unstructured":"Jia L, Fu Y, Shen L, et al. PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer\u2019s disease. Alzheimers Dement. 2020;16(1):178\u201391.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1836_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01493-w","volume":"16","author":"H Nan","year":"2024","unstructured":"Nan H, Kim YJ, Chu M, et al. Genetic and clinical landscape of Chinese frontotemporal dementia: dominance of TBK1 and OPTN mutations. Alzheimers Res Ther. 2024;16(1): 127.","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"1836_CR5","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1002\/alz.14215","volume":"20","author":"T Xu","year":"2024","unstructured":"Xu T, Weng L, Zhang C, et al. Genetic spectrum features and diagnostic accuracy of four plasma biomarkers in 248 Chinese patients with frontotemporal dementia. Alzheimers Dement. 2024;20(10):7281\u201395.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1836_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/humu.9527","volume":"29","author":"C Fouillade","year":"2008","unstructured":"Fouillade C, Chabriat H, Riant F, et al. Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain. Hum Mutat. 2008;29(3):452.","journal-title":"Hum Mutat"},{"issue":"8","key":"1836_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/cns.13647","volume":"27","author":"L Guo","year":"2021","unstructured":"Guo L, Jiao B, Liao X, et al. The role of NOTCH3 variants in Alzheimer\u2019s disease and subcortical vascular dementia in the Chinese population. CNS Neurosci Ther. 2021;27(8):930\u201340.","journal-title":"CNS Neurosci Ther"},{"issue":"6602","key":"1836_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/383707a0","volume":"383","author":"A Joutel","year":"1996","unstructured":"Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383(6602):707\u201310.","journal-title":"Nature"},{"issue":"5","key":"1836_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/14737159.2014.922880","volume":"14","author":"JW Rutten","year":"2014","unstructured":"Rutten JW, Haan J, Terwindt GM, van Duinen SG, Boon EM, Lesnik Oberstein SA. Interpretation of NOTCH3 mutations in the diagnosis of CADASIL. Expert Rev Mol Diagn. 2014;14(5):593\u2013603.","journal-title":"Expert Rev Mol Diagn"},{"issue":"9090","key":"1836_CR10","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(97)08083-5","volume":"350","author":"A Joutel","year":"1997","unstructured":"Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350(9090):1511\u20135.","journal-title":"Lancet"},{"key":"1836_CR11","doi-asserted-by":"publisher","unstructured":"Muino E, Gallego-Fabrega C, Cullell N, et al. Systematic review of cysteine-sparing NOTCH3 missense mutations in patients with clinical suspicion of CADASIL. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18091964.","DOI":"10.3390\/ijms18091964"},{"issue":"13","key":"1836_CR12","doi-asserted-by":"publisher","first-page":"e1835","DOI":"10.1212\/WNL.0000000000010525","volume":"95","author":"JW Rutten","year":"2020","unstructured":"Rutten JW, Hack RJ, Duering M, et al. Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance. Neurology. 2020;95(13):e1835\u201343.","journal-title":"Neurology"},{"issue":"11","key":"1836_CR13","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1212\/01.wnl.0000187068.92184.63","volume":"65","author":"JS Goldman","year":"2005","unstructured":"Goldman JS, Farmer JM, Wood EM, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005;65(11):1817\u20139.","journal-title":"Neurology"},{"issue":"5","key":"1836_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"2","key":"1836_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0014-4886(91)90075-N","volume":"112","author":"F Owen","year":"1991","unstructured":"Owen F, Poulter M, Collinge J, et al. Insertions in the prion protein gene in atypical dementias. Exp Neurol. 1991;112(2):240\u20132.","journal-title":"Exp Neurol"},{"issue":"2","key":"1836_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245\u201356.","journal-title":"Neuron"},{"issue":"3","key":"1836_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1836_CR18","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546\u201354.","journal-title":"Neurology"},{"issue":"Pt 9","key":"1836_CR19","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456\u201377.","journal-title":"Brain"},{"issue":"11","key":"1836_CR20","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006\u201314.","journal-title":"Neurology"},{"issue":"5","key":"1836_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293\u20139.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"1","key":"1836_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.13001","volume":"6","author":"HK Park","year":"2013","unstructured":"Park HK, Chung SJ. New perspective on parkinsonism in frontotemporal lobar degeneration. J Mov Disord. 2013;6(1):1\u20138.","journal-title":"J Mov Disord"},{"issue":"1","key":"1836_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01702-0","volume":"17","author":"H Nan","year":"2025","unstructured":"Nan H, Chu M, Jiang D, et al. Identification and characterization of variants in PSEN1, PSEN2, and APP genes in Chinese patients with early-onset Alzheimer\u2019s disease. Alzheimers Res Ther. 2025;17(1): 54.","journal-title":"Alzheimers Res Ther"},{"issue":"16","key":"1836_CR24","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1093\/hmg\/ddr237","volume":"20","author":"M Duering","year":"2011","unstructured":"Duering M, Karpinska A, Rosner S, et al. Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis. Hum Mol Genet. 2011;20(16):3256\u201365.","journal-title":"Hum Mol Genet"},{"issue":"21","key":"1836_CR25","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.1128\/MCB.24.21.9265-9273.2004","volume":"24","author":"C Sanchez-Irizarry","year":"2004","unstructured":"Sanchez-Irizarry C, Carpenter AC, Weng AP, Pear WS, Aster JC, Blacklow SC. Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol Cell Biol. 2004;24(21):9265\u201373.","journal-title":"Mol Cell Biol"},{"issue":"11","key":"1836_CR26","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/acn3.344","volume":"3","author":"JW Rutten","year":"2016","unstructured":"Rutten JW, Dauwerse HG, Gravesteijn G, et al. Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL. Ann Clin Transl Neurol. 2016;3(11):844\u201353.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"1836_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41436-018-0088-3","volume":"21","author":"JW Rutten","year":"2019","unstructured":"Rutten JW, Van Eijsden BJ, Duering M, et al. The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1\u20136 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7\u201334 pathogenic variant. Genet Med. 2019;21(3):676\u201382.","journal-title":"Genet Med"},{"issue":"8","key":"1836_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s10038-020-0751-9","volume":"65","author":"M Mukai","year":"2020","unstructured":"Mukai M, Mizuta I, Watanabe-Hosomi A, et al. Genotype-phenotype correlations and effect of mutation location in Japanese CADASIL patients. J Hum Genet. 2020;65(8):637\u201346.","journal-title":"J Hum Genet"},{"issue":"1","key":"1836_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01660-0","volume":"20","author":"R He","year":"2020","unstructured":"He R, Li H, Sun Y, et al. Homozygous NOTCH3 p. R587C mutation in Chinese patients with CADASIL: a case report. BMC Neurol. 2020;20(1): 72.","journal-title":"BMC Neurol"},{"issue":"9","key":"1836_CR30","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/cns.12719","volume":"23","author":"S Chen","year":"2017","unstructured":"Chen S, Ni W, Yin XZ, et al. Clinical features and mutation spectrum in Chinese patients with CADASIL: a multicenter retrospective study. CNS Neurosci Ther. 2017;23(9):707\u201316.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"1836_CR31","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.014","volume":"26","author":"J You","year":"2017","unstructured":"You J, Liao S, Zhang F, Ma Z, Li G. First report of Arg587Cys mutation of Notch3 gene in two Chinese families with CADASIL. J Stroke Cerebrovasc Dis. 2017;26(1):e1\u20134.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"8","key":"1836_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136501","volume":"10","author":"YC Liao","year":"2015","unstructured":"Liao YC, Hsiao CT, Fuh JL, et al. Characterization of CADASIL among the Han Chinese in Taiwan: distinct genotypic and phenotypic profiles. PLoS ONE. 2015;10(8): e0136501.","journal-title":"PLoS ONE"},{"issue":"8","key":"1836_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136352","volume":"10","author":"LL Kilarski","year":"2015","unstructured":"Kilarski LL, Rutten-Jacobs LC, Bevan S, et al. Prevalence of CADASIL and Fabry disease in a cohort of MRI defined younger onset lacunar stroke. PLoS ONE. 2015;10(8): e0136352.","journal-title":"PLoS ONE"},{"issue":"10","key":"1836_CR34","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1212\/01.wnl.0000216259.99811.50","volume":"66","author":"Y Kim","year":"2006","unstructured":"Kim Y, Choi EJ, Choi CG, et al. Characteristics of CADASIL in Korea: a novel cysteine-sparing Notch3 mutation. Neurology. 2006;66(10):1511\u20136.","journal-title":"Neurology"},{"key":"1836_CR35","doi-asserted-by":"crossref","unstructured":"Yoon CW, Kim YE, Seo SW, et al. NOTCH3 variants in patients with subcortical vascular cognitive impairment: a comparison with typical CADASIL patients. Neurobiol Aging. 2015;36(8):2443 e2441\u20132447.","DOI":"10.1016\/j.neurobiolaging.2015.04.009"},{"key":"1836_CR36","doi-asserted-by":"publisher","unstructured":"Kim Y, Lee SH. Novel characteristics of race-specific genetic functions in Korean CADASIL. Medicina (Kaunas). 2019. https:\/\/doi.org\/10.3390\/medicina55090521.","DOI":"10.3390\/medicina55090521"},{"key":"1836_CR37","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.2147\/NDT.S142321","volume":"13","author":"J Wang","year":"2017","unstructured":"Wang J, Li J, Kong F, Lv H, Guo Z. Bipolar II disorder as the initial presentation of CADASIL: an underdiagnosed manifestation. Neuropsychiatr Dis Treat. 2017;13:2175\u20139.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"1836_CR38","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1111\/cns.13917","volume":"28","author":"W Ni","year":"2022","unstructured":"Ni W, Zhang Y, Zhang L, Xie JJ, Li HF, Wu ZY. Genetic spectrum of NOTCH3 and clinical phenotype of CADASIL patients in different populations. CNS Neurosci Ther. 2022;28(11):1779\u201389.","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"1836_CR39","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1038\/s41380-018-0224-0","volume":"25","author":"C Koriath","year":"2020","unstructured":"Koriath C, Kenny J, Adamson G, et al. Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series. Mol Psychiatry. 2020;25(12):3399\u2013412.","journal-title":"Mol Psychiatry"},{"key":"1836_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpsychires.2019.03.026","volume":"113","author":"G Wang","year":"2019","unstructured":"Wang G, Zhang DF, Jiang HY, et al. Mutation and association analyses of dementia-causal genes in Han Chinese patients with early-onset and familial Alzheimer\u2019s disease. J Psychiatr Res. 2019;113:141\u20137.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1836_CR41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00415-014-7533-2","volume":"262","author":"S Bianchi","year":"2015","unstructured":"Bianchi S, Zicari E, Carluccio A, et al. CADASIL in central Italy: a retrospective clinical and genetic study in 229 patients. J Neurol. 2015;262(1):134\u201341.","journal-title":"J Neurol"},{"issue":"5","key":"1836_CR42","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/nan.12073","volume":"40","author":"LJ Craggs","year":"2014","unstructured":"Craggs LJ, Yamamoto Y, Ihara M, et al. White matter pathology and disconnection in the frontal lobe in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neuropathol Appl Neurobiol. 2014;40(5):591\u2013602.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"9","key":"1836_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075035","volume":"8","author":"OA Ross","year":"2013","unstructured":"Ross OA, Soto-Ortolaza AI, Heckman MG, et al. NOTCH3 variants and risk of ischemic stroke. PLoS ONE. 2013;8(9): e75035.","journal-title":"PLoS ONE"},{"issue":"6","key":"1836_CR44","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1161\/STROKEAHA.108.528299","volume":"40","author":"Y Yamamoto","year":"2009","unstructured":"Yamamoto Y, Ihara M, Tham C, et al. Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke. 2009;40(6):2004\u201311.","journal-title":"Stroke"},{"issue":"Pt 4","key":"1836_CR45","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/brain\/awn364","volume":"132","author":"S Tikka","year":"2009","unstructured":"Tikka S, Mykkanen K, Ruchoux MM, et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain. 2009;132(Pt 4):933\u20139.","journal-title":"Brain"},{"issue":"1","key":"1836_CR46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/01.STR.0000251787.90695.05","volume":"38","author":"JS Keverne","year":"2007","unstructured":"Keverne JS, Low WC, Ziabreva I, Court JA, Oakley AE, Kalaria RN. Cholinergic neuronal deficits in CADASIL. Stroke. 2007;38(1):188\u201391.","journal-title":"Stroke"},{"issue":"7","key":"1836_CR47","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/archneur.62.7.1091","volume":"62","author":"N Peters","year":"2005","unstructured":"Peters N, Opherk C, Bergmann T, Castro M, Herzog J, Dichgans M. Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch Neurol. 2005;62(7):1091\u20134.","journal-title":"Arch Neurol"},{"issue":"Pt 11","key":"1836_CR48","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1093\/brain\/awh282","volume":"127","author":"C Opherk","year":"2004","unstructured":"Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain. 2004;127(Pt 11):2533\u20139.","journal-title":"Brain"},{"issue":"11","key":"1836_CR49","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1177\/0333102415618613","volume":"36","author":"R Samoes","year":"2016","unstructured":"Samoes R, Alves JE, Taipa R, Silva J, Melo Pires M, Pereira-Monteiro JM. CADASIL: MRI may be normal in the fourth decade of life - a case report. Cephalalgia. 2016;36(11):1082\u20135.","journal-title":"Cephalalgia"},{"issue":"7","key":"1836_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106541","volume":"31","author":"L Hu","year":"2022","unstructured":"Hu L, Liu G, Fan Y. R558C NOTCH3 mutation in a CADASIL patient with intracerebral hemorrhage: a case report with literature review. J Stroke Cerebrovasc Dis. 2022;31(7): 106541.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"1836_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1212\/WNL.0b013e31823fcd3c","volume":"78","author":"T Chitnis","year":"2012","unstructured":"Chitnis T, Hollmann TJ. CADASIL mutation and Balo concentric sclerosis: a link between demyelination and ischemia? Neurology. 2012;78(3):221\u20133.","journal-title":"Neurology"},{"issue":"6","key":"1836_CR52","first-page":"821","volume":"34","author":"Z Ren","year":"2017","unstructured":"Ren Z, Chen S, Shi Y, et al. CADASIL with clinical manifestations of baldness, lumbago and Parkinson\u2019s symptoms. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017;34(6):821\u20135.","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"issue":"4","key":"1836_CR53","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/STROKEAHA.119.027474","volume":"51","author":"A Ilinca","year":"2020","unstructured":"Ilinca A, Martinez-Majander N, Samuelsson S, et al. Whole-exome sequencing in 22 young ischemic stroke patients with familial clustering of stroke. Stroke. 2020;51(4):1056\u201363.","journal-title":"Stroke"},{"key":"1836_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.705284","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu Y, Sun Q, Zhou Y, et al. NOTCH3 variants and genotype-phenotype features in Chinese CADASIL patients. Front Genet. 2021;12: 705284.","journal-title":"Front Genet"},{"issue":"2","key":"1836_CR55","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00415-009-0091-3","volume":"256","author":"YC Lee","year":"2009","unstructured":"Lee YC, Liu CS, Chang MH, et al. Population-specific spectrum of NOTCH3 mutations, MRI features and founder effect of CADASIL in Chinese. J Neurol. 2009;256(2):249\u201355.","journal-title":"J Neurol"},{"key":"1836_CR56","first-page":"23","volume":"59","author":"T Erkinjuntti","year":"2000","unstructured":"Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl. 2000;59:23\u201330.","journal-title":"J Neural Transm Suppl"},{"issue":"6","key":"1836_CR57","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.ajhg.2013.04.024","volume":"92","author":"JA Martignetti","year":"2013","unstructured":"Martignetti JA, Tian L, Li D, et al. Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. Am J Hum Genet. 2013;92(6):1001\u20137.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"1836_CR58","doi-asserted-by":"publisher","first-page":"848","DOI":"10.15252\/emmm.201404399","volume":"7","author":"T Pippucci","year":"2015","unstructured":"Pippucci T, Maresca A, Magini P, et al. Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathy. EMBO Mol Med. 2015;7(6):848\u201358.","journal-title":"EMBO Mol Med"},{"issue":"Pt 11","key":"1836_CR59","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1093\/brain\/awr252","volume":"134","author":"H Schmidt","year":"2011","unstructured":"Schmidt H, Zeginigg M, Wiltgen M, et al. Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease. Brain. 2011;134(Pt 11):3384\u201397.","journal-title":"Brain"},{"key":"1836_CR60","doi-asserted-by":"crossref","unstructured":"Sassi C, Nalls MA, Ridge PG, et al. Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3. Neurobiol Aging. 2018;66:179 e117\u2013179 e129.","DOI":"10.1016\/j.neurobiolaging.2018.01.015"},{"issue":"6727","key":"1836_CR61","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/19083","volume":"398","author":"B De Strooper","year":"1999","unstructured":"De Strooper B, Annaert W, Cupers P, et al. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature. 1999;398(6727):518\u201322.","journal-title":"Nature"},{"issue":"5","key":"1836_CR62","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1172\/JCI8047","volume":"105","author":"A Joutel","year":"2000","unstructured":"Joutel A, Andreux F, Gaulis S, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest. 2000;105(5):597\u2013605.","journal-title":"J Clin Invest"},{"key":"1836_CR63","doi-asserted-by":"crossref","unstructured":"Guerreiro RJ, Lohmann E, Kinsella E, et al. Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease. Neurobiol Aging. 2012;33(5):1008 e1017\u20131023.","DOI":"10.1016\/j.neurobiolaging.2011.10.009"},{"issue":"1","key":"1836_CR64","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40142-019-0160-6","volume":"7","author":"DW Sirkis","year":"2019","unstructured":"Sirkis DW, Geier EG, Bonham LW, Karch CM, Yokoyama JS. Recent advances in the genetics of frontotemporal dementia. Curr Genet Med Rep. 2019;7(1):41\u201352.","journal-title":"Curr Genet Med Rep"},{"issue":"2","key":"1836_CR65","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/NRL.0b013e318247bb2d","volume":"18","author":"HJ Kim","year":"2012","unstructured":"Kim HJ, Kim HY, Paek WK, et al. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration in association with CADASIL. Neurologist. 2012;18(2):92\u20135.","journal-title":"Neurologist"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01836-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01836-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01836-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:47:31Z","timestamp":1757346451000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01836-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1836"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01836-1","relation":{},"ISSN":["1758-9193"],"issn-type":[{"type":"electronic","value":"1758-9193"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committees of the Xuanwu Hospital of Capital Medical University (approval number: 2020026), and it was carried out in compliance with the Declaration of Helsinki\u2019s principles. Written informed consent was obtained from the guardian of each patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the guardian of each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}